Skip to content

Nasdaq · CIK 0001872529

MDXH MDxHealth SA

Insider trading from SEC Form 4. Last filing Aug 17, 2026. Close $0.60 on Oct 12, 2026, +51% from the 52-week low and -88% from the high.

In brief

MDxHealth SA (MDXH) has 10 SEC Form 4 filings on file from 10 insiders, the latest filed on Aug 17, 2026. In the last 90 days insiders made 1 open-market buy worth $1000k and 0 open-market sells worth $0, net +$1000k.

1 open-market trade has been scored at MDXH. The newest: MVM Partners, LLC (director) bought $1000k of stock on Aug 13, 2026, filed Aug 17, 2026, scored 46 (moderate).

1 Form 144 notice of planned sales is on file, the latest filed Sep 17, 2026.

Last 90 days

Net insider value
+$1000k
more bought than sold
Buys
1
$1000k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company

Price and insider trades, last year

MDXHOct 12, 2026 · close 0.60

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at MDxHealth SA, scored.

ScoreInsiderValueHoldingsPrice contextFiled
46ModerateMVM Partners, LLC
director
buy
$1000k
2,202,643 shares
+47%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Sep 17, 2026 Bleichroeder LP
10% Stockholder
1,500,000
1.57% of outstanding
$1.1MSep 17, 2026none

Transactions

Every row filed, 14 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Aug 13, 2026MVM Partners, LLC
director
POpen-market purchase
Ordinary Sharesindirect: See Footnote
+2,202,643$0.45$1000k6,903,100Aug 17, 2026
Jun 1, 2026John Bellano
Chief Commercial Officer
AGrant or award
Share Optionderivative
+116,000$0.00$0116,000Jun 3, 2026
Jun 1, 2026Don M Hardison
director
AGrant or award
Share Optionderivative
+10,000$0.00$010,000Jun 3, 2026
Jun 1, 2026Koen Hoffman
director
AGrant or award
Share Optionderivativeindirect: By Ahok BV
+10,000$0.00$010,000Jun 3, 2026
Jun 1, 2026Michael Holder
director
AGrant or award
Share Optionderivative
+10,000$0.00$010,000Jun 3, 2026
Jun 1, 2026Sanford Jay Siegel
director
AGrant or award
Share Optionderivative
+10,000$0.00$010,000Jun 3, 2026
Jun 1, 2026Hilde Windels
director
AGrant or award
Share Optionderivativeindirect: By Hilde Windels BV
+10,000$0.00$010,000Jun 3, 2026
Jun 1, 2026Michael McGarrity
Chief Executive Officer
AGrant or award
Share Optionderivative
+329,800$0.00$0329,800Jun 3, 2026
Jun 1, 2026Brendan OConnell
VP, Finance and Accounting
AGrant or award
Share Optionderivative
+35,000$0.00$035,000Jun 3, 2026
Jun 1, 2026Joseph Sollee
See Remarks
AGrant or award
Share Optionderivative
+83,000$0.00$083,000Jun 3, 2026
Jun 1, 2026John Bellano
Chief Commercial Officer
AGrant or award
Share Optionderivative
+217,000$0.00$0217,000Jun 3, 2026
Jun 1, 2026Michael McGarrity
Chief Executive Officer
AGrant or award
Share Optionderivative
+612,400$0.00$0612,400Jun 3, 2026
Jun 1, 2026Brendan OConnell
VP, Finance and Accounting
AGrant or award
Share Optionderivative
+65,000$0.00$065,000Jun 3, 2026
Jun 1, 2026Joseph Sollee
See Remarks
AGrant or award
Share Optionderivative
+154,100$0.00$0154,100Jun 3, 2026

Insiders

Everyone who has filed a Form 4 here.

Questions about MDXH

Answered from the filings on this page, as of the latest one.

Are insiders buying MDXH?

As of Aug 17, 2026, SEC Form 4 filings show 1 open-market buy worth $1000k by 1 insider and 0 open-market sells worth $0 by 0 insiders at MDxHealth SA in the last 90 days, net +$1000k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.

Who was the last insider to trade MDXH on the open market?

MVM Partners, LLC (director) bought $1000k of MDXH on Aug 13, 2026 and filed the Form 4 on Aug 17, 2026. InsiderTell scored 46 (moderate).

How many insiders file Form 4 at MDxHealth SA?

10 people have filed a Form 4 at MDxHealth SA, among them John Bellano (Chief Commercial Officer), Don M Hardison (director), Koen Hoffman (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

MDXH insider trading: MDxHealth SA | InsiderTell